Eric I. Richman - 25 May 2022 Form 4 Insider Report for Gain Therapeutics, Inc. (GANX)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Eric I Richman
Issuer symbol
GANX
Transactions as of
25 May 2022
Net transactions value
+$6,404
Form type
4
Filing time
27 May 2022, 16:10:32 UTC
Previous filing
23 May 2022
Next filing
12 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GANX Common stock Purchase $6,404 +2,482 +1.2% $2.58 217,729 25 May 2022 Direct
holding GANX Common stock 14,829 25 May 2022 By Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares are held by the Eric I. Richman Living Trust (the "Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of the shares held by the Trust except to the extent of his proportionate pecuniary iinterest therein.